Severe acute pancreatitis: surgical indications and treatment.

Endoscopic Infection Minimally invasive surgery Necrosectomy Pancreatic necrosis Percutaneous

Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
May 2021
Historique:
received: 11 07 2020
accepted: 21 07 2020
pubmed: 11 9 2020
medline: 25 9 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Acute pancreatitis (AP) is defined as an acute inflammatory attack of the pancreas of sudden onset. Around 25% of patients have either moderately severe or severe disease with a mortality rate of 15-20%. The aim of this article was to summarize the advances being made in the understanding of this disease and the important role of surgery. An accurate diagnosis should be made a soon as possible, initiating resuscitation with large volume intravenous fluids and oxygen by mask. Predicted severe disease will require intensive monitoring. Most deaths within the first week are due to multi-organ failure; thus, these patients will require intensive therapy unit management. During the second phase of the disease, death is due to local complications arising from the pancreatic inflammation, requiring accurate identification to determine the correct form of treatment. Acute peripancreatic fluid collections arise < 4 weeks after onset of interstitial edematous pancreatitis, not requiring any treatment. Most pancreatic pseudocysts arise > 4 weeks and largely resolve on conservative management. Necrotizing pancreatitis causing acute necrotic collections and later walled-off necrosis will require treatment if symptomatic or infected. Initial endoscopic transgastric or percutaneous drainage will resolve less serious collections but necrosectomy using minimally invasive approaches will be needed for more serious collections. To prevent recurrent attacks of AP, causative factors need to be removed where possible such as cholecystectomy and cessation of alcohol. Future progress requires improved management of multi-organ failure and more effective minimally invasive techniques for the removal of necrosis.

Sections du résumé

BACKGROUND BACKGROUND
Acute pancreatitis (AP) is defined as an acute inflammatory attack of the pancreas of sudden onset. Around 25% of patients have either moderately severe or severe disease with a mortality rate of 15-20%.
PURPOSE OBJECTIVE
The aim of this article was to summarize the advances being made in the understanding of this disease and the important role of surgery.
RESULTS AND CONCLUSIONS CONCLUSIONS
An accurate diagnosis should be made a soon as possible, initiating resuscitation with large volume intravenous fluids and oxygen by mask. Predicted severe disease will require intensive monitoring. Most deaths within the first week are due to multi-organ failure; thus, these patients will require intensive therapy unit management. During the second phase of the disease, death is due to local complications arising from the pancreatic inflammation, requiring accurate identification to determine the correct form of treatment. Acute peripancreatic fluid collections arise < 4 weeks after onset of interstitial edematous pancreatitis, not requiring any treatment. Most pancreatic pseudocysts arise > 4 weeks and largely resolve on conservative management. Necrotizing pancreatitis causing acute necrotic collections and later walled-off necrosis will require treatment if symptomatic or infected. Initial endoscopic transgastric or percutaneous drainage will resolve less serious collections but necrosectomy using minimally invasive approaches will be needed for more serious collections. To prevent recurrent attacks of AP, causative factors need to be removed where possible such as cholecystectomy and cessation of alcohol. Future progress requires improved management of multi-organ failure and more effective minimally invasive techniques for the removal of necrosis.

Identifiants

pubmed: 32910276
doi: 10.1007/s00423-020-01944-6
pii: 10.1007/s00423-020-01944-6
pmc: PMC8106572
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-535

Subventions

Organisme : Department of Health
ID : PB-PG-0407-13363
Pays : United Kingdom

Références

Whitcomb DC (2019) Pancreatitis: TIGAR-O version 2 risk/etiology checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol 10(6):e00027. https://doi.org/10.14309/ctg.0000000000000027
doi: 10.14309/ctg.0000000000000027 pubmed: 31166201 pmcid: 6613863
Yadav D, Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 144(6):1252–1261
pubmed: 23622135 pmcid: 3662544
Gryshchenko O, Gerasimenko JV, Peng S, Gerasimenko OV, Petersen OH (2018) Calcium signalling in the acinar environment of the exocrine pancreas: physiology and pathophysiology. J Physiol 596(14):2663–2678
pubmed: 29424931 pmcid: 6046068
Romac JMJ, Shahid RA, Swain SM, Vigna SR, Liddle RA (2018) Piezo1 is a mechanically activated ion channel and mediates pressure induced pancreatitis. Nat Commun 9(1):1715. Published 2018 Apr 30. https://doi.org/10.1038/s41467-018-04194-9
doi: 10.1038/s41467-018-04194-9 pubmed: 29712913 pmcid: 5928090
Pallagi P, Madácsy T, Varga Á, Maléth J (2020) Intracellular Ca2+ signalling in the pathogenesis of acute pancreatitis: recent advances and translational perspectives. Int J Mol Sci 21(11):1–18
Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C et al (2001) Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut. 48(1):62–69
pubmed: 11115824 pmcid: 1728186
Raraty MGT, Connor S, Criddle DN, Sutton R, Neoptolemos JP (2004) Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 6(2):99–103
pubmed: 15191686
Petrov MS, Yadav D (2019) Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 16(3):175–184
pubmed: 30482911 pmcid: 6597260
Roberts SE, Morrison-Rees S, John A, Williams JG, Brown TH, Samuel DG (2017) The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 17(2):155–165
pubmed: 28159463
Hamada S, Masamune A, Kikuta K, Hirota M, Tsuji I, Shimosegawa T (2014) Nationwide epidemiological survey of acute pancreatitis in Japan. Pancreas. 43(8):1244–1248
pubmed: 25084001
Fagenholz PJ, Fernández-Del Castillo C, Harris NS, Pelletier AJ, Camargo CA (2007) Direct medical costs of acute pancreatitis hospitalizations in the United States. Pancreas. 35(4):302–307
pubmed: 18090234
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG et al (2013) Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 62(1):102–111
pubmed: 23100216
Van DIjk SM, Hallensleben NDL, Van Santvoort HC, Fockens P, Van Goor H, Bruno MJ et al (2017) Acute pancreatitis: recent advances through randomised trials. Gut. 66(11):2024–2032
pubmed: 28838972
Raraty MGT, Halloran CM, Dodd S, Ghaneh P, Connor S, Evans J et al (2010) Minimal access retroperitoneal pancreatic necrosectomy: improvement in morbidity and mortality with a less invasive approach. Ann Surg 251(5):787–793
pubmed: 20395850
Gomatos IP, Halloran CM, Ghaneh P, Raraty MGT, Polydoros F, Evans JC et al (2016) Outcomes from minimal access retroperitoneal and open pancreatic necrosectomy in 394 patients with necrotizing pancreatitis. Ann Surg 263(5):992–1001
pubmed: 26501713
Beger HG, Bittner R, Block S, Büchler M (1986) Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 91(2):433–438
pubmed: 3522342
Connor S, Alexakis N, Neal T, Raraty M, Ghaneh P, Evans J et al (2004) Fungal infection but not type of bacterial infection is associated with a high mortality in primary and secondary infected pancreatic necrosis. Dig Surg 21(4):297–304
pubmed: 15365228
Werge M, Novovic S, Schmidt PN, Gluud LL (2016) Infection increases mortality in necrotizing pancreatitis: a systematic review and meta-analysis. Pancreatology. 16(5):698–707
pubmed: 27449605
Dellinger EP, Forsmark CE, Layer P, Lévy P, Maraví-Poma E, Petrov MS et al (2012) Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg 256(6):875–880
pubmed: 22735715
(2013) IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 13(4 SUPPL. 2):e1–e15
Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23(10):1638–1652
pubmed: 7587228
Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MGT, Slavin J et al (2000) Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 355(9219):1955–1960
pubmed: 10859041
Gomatos IP, Xiaodong X, Ghaneh P, Halloran C, Raraty M, Lane B et al (2014) Prognostic markers in acute pancreatitis. Expert Rev Mol Diagn 14(3):333–346
pubmed: 24649820
Neoptolemos JP, London NJ, James D, Carr-Locke DL, Bailey IA, Fossard DP (1988) Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 332(8618):979–983
Fan ST, Lai E, Mok F, Lo CM, Zheng, Sen S, Wong J (1993) Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 328(4):228–232
pubmed: 8418402
Van Santvoort HC, Besselink MG, De Vries AC, Boermeester MA, Fischer K, Bollen TL et al (2009) Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study. Ann Surg 250(1):68–75
pubmed: 19561460
Schepers NJ, Hallensleben NDL, Besselink MG, Anten MGF, Bollen TL, da Costa DW et al (2020) Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial. Lancet 396(10245):167–176
Fagniez P-L, Rotman N, Kracht M (1989) Direct retroperitoneal approach to necrosis in severe acute pancreatitis. Br J Surg 76(3):264–267
pubmed: 2720323
Carter CR, McKay CJ, Imrie CW (2000) Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg 232(2):175–180
pubmed: 10903593 pmcid: 1421126
Connor S, Ghaneh P, Raraty M, Sutton R, Rosso E, Garvey CJ et al (2003) Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg 20(4):270–277
pubmed: 12748429
Van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA, Dejong CH et al (2010) A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med 362(16):1491–1502
pubmed: 20410514
Rische S, Riecken B, Degenkolb J, Kayser T, Caca K (2013) Transmural endoscopic necrosectomy of infected pancreatic necroses and drainage of infected pseudocysts: a tailored approach. Scand J Gastroenterol 48(2):231–240
pubmed: 23268585
Kumar N, Conwell DL, Thompson CC (2014) Direct endoscopic necrosectomy versus step-up approach for walled-off pancreatic necrosis comparison of clinical outcome and health care utilization. Pancreas. 43(8):1334–1339
pubmed: 25083997 pmcid: 5019103
van Brunschot S, van Grinsven J, van Santvoort HC, Bakker OJ, Besselink MG, Boermeester MA et al (2018) Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial. Lancet 391(10115):51–58
pubmed: 29108721
van Brunschot S, Hollemans RA, Bakker OJ, Besselink MG, Baron TH, Beger HG et al (2018) Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients. Gut. 67(4):697–706
pubmed: 28774886
Hollemans RA, Bakker OJ, Boermeester MA, Bollen TL, Bosscha K, Bruno MJ et al (2019) Superiority of step-up approach vs open necrosectomy in long-term follow-up of patients with necrotizing pancreatitis. Gastroenterology. 156(4):1016–1026
pubmed: 30391468
Driedger M, Zyromski NJ, Visser BC, Jester A, Sutherland FR, Nakeeb A et al (2020) Surgical transgastric necrosectomy for necrotizing pancreatitis: a single-stage procedure for walled-off pancreatic necrosis. Ann Surg 271(1):163–168
pubmed: 30216220
Saunders R, Ramesh J, Cicconi S, Evans J, Yip VS, Raraty M et al (2019) A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous. Surg Endosc 33(5):1412–1425
pubmed: 30191310
Götzinger P, Sautner T, Kriwanek S, Beckerhinn P, Barlan M, Armbruster C et al (2002) Surgical treatment for severe acute pancreatitis: extent and surgical control of necrosis determine outcome. World J Surg 26(4):474–478
pubmed: 11910483
Werner J, Feuerbach S, Uhl W, Büchler MW (2005) Management of acute pancreatitis: from surgery to interventional intensive care. Gut. 54(3):426–436
pubmed: 15710995 pmcid: 1774421
Babu RY, Gupta R, Kang M, Bhasin DK, Rana SS, Singh R (2013) Predictors of surgery in patients with severe acute pancreatitis managed by the step-up approach. Ann Surg 257(4):737–750
pubmed: 22968079
Mier J, Luque-De León E, Castillo A, Robledo F, Blanco R (1997) Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 173(2):71–75
pubmed: 9074366
van Grinsven J, van Brunschot S, Bakker OJ, Bollen TL, Boermeester MA, Bruno MJ et al (2016) Diagnostic strategy and timing of intervention in infected necrotizing pancreatitis: an international expert survey and case vignette study. HPB 18(1):49–56
pubmed: 26776851
Nieuwenhuijs VB, Besselink MGH, Van Minnen LP, Gooszen HG (2003) Surgical management of acute necrotizing pancreatitis: a 13-year experience and a systematic review. Scand J Gastroenterol Suppl 239:111–116
Sarr MG, Nagorney DM, Mucha P, Farnell MB, Johnson CD (1991) Acute necrotizing pancreatitis: management by planned, staged pancreatic necrosectomy/debridement and delayed primary wound closure over drains. Br J Surg 78(5):576–581
pubmed: 2059810
Beger HG, Büchler M, Bittner R, Block S, Nevalainen T, Roscher R (1988) Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg 75(3):207–212
pubmed: 3349326
Büchler MW, Gloor B, Müller CA, Friess H, Seiler CA, Uhl W (2000) Acute necrotizing pancreatitis: treatment strategy according to th status of infection. Ann Surg 232(5):619–622
pubmed: 11066131 pmcid: 1421214
Del Castillo CF, Rattner DW, Makary MA, Mostafavi A, McGrath D, Warshaw AL (1998) Débridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg 228(5):676–684
Rodriguez JR, Razo AO, Targarona J, Thayer SP, Rattner DW, Warshaw AL et al (2008) Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients. Ann Surg 247(2):294–299
pubmed: 18216536 pmcid: 3806106
Husu HL, Kuronen JA, Leppäniemi AK, Mentula PJ (2020) Open necrosectomy in acute pancreatitis-obsolete or still useful? World J Emerg Surg 15(1):21. https://doi.org/10.1186/s13017-020-00300-9
doi: 10.1186/s13017-020-00300-9 pubmed: 32183878 pmcid: 7079510
Block S, Maier W, Clausen C, Büchler M, Malfertheiner P, Beger HG (1985) Diagnosis of necrotising pancreatitis. Comparison of contrast-enhanced CT and ultrasound in a clinical study. Dtsch Med Wochenschr 110(21):826–832
pubmed: 3888588
London NJM, Neoptolemos JP, Lavelle J, Bailey I, James D (1989) Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg 76(3):268–272
pubmed: 2720324
Balthazar EJ, Robinson DL, Megibow AJ, Ranson JHC (1990) Acute pancreatitis: value of CT in establishing prognosis. Radiology. 174(2):331–336
pubmed: 2296641
Wang PF, Liu ZW, Cai SW, Su JJ, He L, Feng J et al (2018) Usefulness of three-dimensional visualization technology in minimally invasive treatment for infected necrotizing pancreatitis. World J Gastroenterol 24(17):1911–1918
pubmed: 29740206 pmcid: 5937208
van Santvoort HC, Besselink MGH, Horvath KD, Sinanan MN, Bollen TL, van Ramshorst B et al (2007) Videoscopic assisted retroperitoneal debridement in infected necrotizing pancreatitis. HPB. 9(2):156–159
pubmed: 18333133 pmcid: 2020795
Bang JY, Arnoletti JP, Holt BA, Sutton B, Hasan MK, Navaneethan U et al (2019) An endoscopic transluminal approach, compared with minimally invasive surgery, reduces complications and costs for patients with necrotizing pancreatitis. Gastroenterology. 156(4):1027–1040.e3
pubmed: 30452918
Van Santvoort HC, Bakker OJ, Bollen TL, Besselink MG, Ahmed Ali U, Schrijver AM et al (2011) A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology. 141(4):1254–1263
pubmed: 21741922
Luckhurst CM, El Hechi M, Elsharkawy AE, Eid AI, Maurer LR, Kaafarani HM et al (2020) Improved mortality in necrotizing pancreatitis with a multidisciplinary minimally invasive step-up approach: comparison with a modern open necrosectomy cohort. J Am Coll Surg 230:873–883
pubmed: 32251846
Baron TH, DiMaio CJ, Wang AY, Morgan KA (2020) American Gastroenterological Association clinical practice update: management of pancreatic necrosis. Gastroenterology. 158(1):67–75.e1
pubmed: 31479658
Van Minnen LP, Besselink MGH, Bosscha K, Van Leeuwen MS, Schipper MEI, Gooszen HG (2004) Colonic involvement in acute pancreatitis: a retrospective study of 16 patients. Dig Surg 21(1):33–38
pubmed: 14707391
Gao L, Zhang J-Z, Gao K, Zhou J, Li G, Li B-Q et al (2020) Management of colonic fistulas in patients with infected pancreatic necrosis being treated with a step-up approach. HPB (Oxford) 2020:S1365-182X(20)30108-8
Flati G, Andrén-Sandberg Å, La Pinta M, Porowska B, Carboni M (2003) Potentially fatal bleeding in acute pancreatitis: pathophysiology, prevention, and treatment. Pancreas. 26(1):8–14
pubmed: 12499910
Connor S, Alexakis N, Raraty MGT, Ghaneh P, Evans J, Hughes M et al (2005) Early and late complications after pancreatic necrosectomy. Surgery. 137(5):499–505
pubmed: 15855920
Neoptolemos JP, London NJM, Carr-Locke DL (1993) Assessment of main pancreatic duct integrity by endoscopic retrograde pancreatography in patients with acute pancreatitis. Br J Surg 80(1):94–99
pubmed: 8428306
van Dijk SM, Timmerhuis HC, Verdonk RC, Reijnders E, Bruno MJ, Fockens P et al (2019) Treatment of disrupted and disconnected pancreatic duct in necrotizing pancreatitis: a systematic review and meta-analysis. Pancreatology. 19(7):905–915
pubmed: 31473083
Da Costa DW, Bouwense SA, Schepers NJ, Besselink MG, Van Santvoort HC, Van Brunschot S et al (2015) Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet 386(10000):1261–1268
pubmed: 26460661
Nealon WH, Bawduniak J, Walser EM (2004) Appropriate timing of cholecystectomy in patients who present with moderate to severe gallstone-associated acute pancreatitis with peripancreatic fluid collections. Ann Surg 239(6):741–751
pubmed: 15166953 pmcid: 1356283

Auteurs

Max Heckler (M)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Baden-Württemberg, Germany.

Thilo Hackert (T)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Baden-Württemberg, Germany.

Kai Hu (K)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Baden-Württemberg, Germany.

Cristopher M Halloran (CM)

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

Markus W Büchler (MW)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Baden-Württemberg, Germany.

John P Neoptolemos (JP)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Baden-Württemberg, Germany. john.neoptolemos@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH